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TO THE EDITOR
Inversa recessive dystrophic epidermo-
lysis bullosa (RDEB-I) is a rare form of
dystrophic epidermolysis bullosa (DEB)
characterized by a peculiar course.
Generalized blistering occurs in the
neonatal period, which in early child-
hood heals with atrophic scars. The
condition improves with age, subsiding
to a predominance of flexural involve-
ments in adults, mainly in inguinal,
perineal, axillary, cervical, and sub-
mammary folds. The progressive ame-
lioration of skin fragility is concomitant
with the development of severe lesions
of the oral, esophageal, anal, and
genital mucosas (Fine et al., 2008). As
in the more recurrent forms of DEB, the
bullae present a cleavage plane within
the upper papillary dermis of the
dermal–epidermal junction. RDEB-I
has been associated with genetic muta-
tions in the COL7A1 gene, which codes
for collagen type VII (Col7), the major
component of the anchoring fibrils of
the dermis (Christiano et al., 1996).
Patients with RDEB present mutations
on both COL7A1 alleles, and may thus
either lack expression or express a
mutated form of Col7, which, respec-
tively, define the most severe Hallopeau–-
Siemens form or the milder clinical
forms of the disease. On the other hand,
patients with dominant DEB always
express abnormal Col7 molecules,
which harbor mutations that exert
a dominant-negative effect on the
protein. The fact that only seven pa-
tients with RDEB-I have been geno-
typed to date has hampered the
establishment of a precise genotype–
phenotype correlation. In this study, we
report six new cases of RDEB-I and the
identification of six genetic mutations
in COL7A1 that are, to our knowledge,
previously unreported. These data, to-
gether with the information available in
the literature, link RDEB-I to missense
mutations at specific positions of the
Col7 polypeptide, which allows for a
hypothesis on their effect on the stabi-
lity of the molecule, and provides hints
on early diagnostic indications.
Supplementary Table S1 online sum-
marizes the clinical features of the
patients. Skin specimens of patients 1,
4, 5, and 6 were analyzed by immuno-
histochemistry using antibodies specific
to the major components of the base-
ment membrane of the dermal–epider-
mal junction (Charlesworth et al.,
2003). Epitope mapping detected a
cleavage within the papillary dermis,
which is the hallmark characteristic
of DEB, and immunoreactive Col7 at
the blister roof, with a reduced intensity
of the signal in patients 4, 5, and 6.
However, no correlation existed be-
tween the staining pattern and the
clinical picture. All the other major
antigens of the basement membrane
zone were expressed at the blister roof.
Direct DNA sequencing of genomic
DNA identified nine genetic mutations
in COL7A1 gene, six of which, to our
knowledge, are previously unreported
(Figure 1). Patient 1 was homozygous
for a missense mutation. Patients 2–6
were compound heterozygotes for a
missense mutation and a premature
termination codon inherited from het-
erozygous healthy carrier parents,
which attests for the recessive inheri-
tance of the condition, because the
negative effect of the missense muta-
tions is complemented by a wild-type
COL7A1 allele. In addition, the differ-
ent premature termination codons
found in compound heterozygosity
clearly do not influence the clinical
phenotype (Figure 1 and Supplemen-
tary Table S1 online).
The large constellation of genetic
mutations identified in DEB has al-
lowed for a relatively clear genotype–
phenotype correlation between severe
RDEB-HS and the homozygous or
heterozygous combination of genetic
mutations that hamper expression of the
COL7A1 alleles. However, a genotype–
phenotype correlation still remains
elusive for a number of DEB variants,
including RDEB-I. Combining the
results of the mutation analysis on
the RDEB-I families identified so far
(Figure 1a), the condition seems to be
associated with missense mutations
involving four arginine or four glycine,
all falling within the carboxyl portion of
the triple helix domain (THD) (Figure
1b). The THD domain is composed of
repeating Gly–X–Y sequences that fold
into a triple helix, which contains 19
imperfections/interruptions generating
20 distinct subdomains (COL1–COL20)
that are highly conserved among spe-
cies (Christiano et al., 1994). The
conservation of Gly residues in every
third position of the amino-acid se-
quence is required for the tied packing
of the triple helix in which glycines are
placed in the center and the X and Y
residues are exposed at the surface.
Therefore, glycine substitutions highly
destabilize the triple helix. In contrast
to other collagens, the potential dis-
ruptive effect of glycine substitutions in
Col7 is reduced by the presence of
the short non-collagenous interruptions
that are thought to provide conforma-
tional flexibility to the THD (Persikov
et al., 2004).
Identification of the novel mutation
R2628W in our patient links RDEB-I
with arginine substitutions involving
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two pairs of residues (R2063G/R2069C
and R2622W/R2628W), each found
at the Y position within the hydro-
philic motifs 2061GERGEKGER2069 and
2620GPRGLKGER2628, which are highly
conserved among species (Figure 1 and
Supplementary Figure S1). Specifically,
residues R2622 and R2628 within
subdomain COL19 juxtapose cysteine
2634, which is thought to mediate
disulfide bonds with the non-collage-
nous domain (NC2) of another collagen
VII molecule. The substitution of
the large hydrophilic arginine residue
by a large hydrophobic tryptophane is,
therefore, likely to modify both the
tertiary and quaternary structure of
Col7 and the intermolecular interac-
tions of Col7, with slightly weakened
stability or folding of the molecule
(Woodley et al., 2008), which results
in the very localized involvements
observed in patient 4 (Supplementary
Table S1 online). In comparison,
residues R2063 and R2069 fall within
subdomain COL12, which is consid-
ered crucial for the function of collagen
VII (Christiano et al., 1994). Substitution
of a large arginine by either a small polar
(glycine2063) or a non-polar (cysteine2069)
residue, which preserves hydration of
polypeptide 2061GERGEKGER2069 by the
surrounding aqueous environment, thus
causes the peculiar inversa form
of RDEB, whereas the disruptive
substitution with a large hydrophobic
...AGPRGEKGEAAL...
NC1 NC2
G1907D
G2472D
G2775S
R2063G
COL12
COL10
COL18
COL20
COL19
...GERGEKGERGEQ...GPPGPPGPK
...GFPGVPGGT...
...GAGLPGPRGER...
...GPRGLKGERGVKGACGLDGEK...
G2088R
R2622W R2628W *
27831254
VSVDEPGP...
Case Mutation  Exon Nucleotide change Consequence Reference 
1
G2775S
8323 G Missense
Missense
This study
2–3
R1340X
68
34
5720–21 GA AT
4018 C T
Missense
PTC
This study
4
Y444X
106
10
7882 C T
1332 C A
Missense
PTC
This study
5
1874del2
97
14
7415 G A
1874del2
Missense
PTC
This study
6
R226X
75
5
6262 G A
676 C T
Missense
PTC
This study
7
R236X
74
6
6187 C G
706 C T
Missense
PTC
Hovnanian et al. (1994) Am J Hum Genet 55: 289
8
2482delCT
105
19
7864 C T
2482delCT
Missense
PTC
Gardella et al. (2002) J Invest Dermatol 19: 1456
9
425 A/G 
112
3
8323 G A
425 A G
Missense
PTC
Zimmer et al. (2002) Gastroenterology 122: 220
10–
11
R2069C
425 A/G
74
3
6205 C T
425 A G
Missense
PTC
Kahofer et al. (2003) Pediatr Dermatol 20: 243
12
R185X
105
5
7864 C T
553 C T
Missense
PTC
Escámez et al. (2010) Br J Dermatol, in press
AG2775S
G1907D
R2628W
G2472D
G2088R
R2063G
R2622W
G2775S
R2622W
112
R2069C
Figure 1. Genetic mutations associated with inversa recessive dystrophic epidermolysis bullosa (RDEB-I). (a) Genotype of the RDEB-I patients.
(b) Representation of the collagen type VII (Col7) molecule, and localization of the genetic mutations associated with RDEB-I. Col7 is a homotrimeric
adhesion molecule that harbors a 145-kDa central collagenous segment (THD) flanked by a large N-terminal (NC1) and a small C-terminal non-collagenous
domain (NC2). Black bars indicate the 19 non-collagenic interruptions and imperfections of THD. The amino-acid sequence of the five collagenic
domains (COL) affected by the arginine (bold R) or glycine substitutions (bold G) found in RDEB-I are reported. The non-collagenic interruptions are in
small capitals in light gray italics, and the hydrophilic motifs 2061GERGEKGER2069 and 2620GPRGLKGER2628 are underlined. Cysteine 2634, which mediates
intramolecular interactions between Col7 monomers, is indicated (*).
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tryptophane results in severe RDEB-HS
(Hovnanian et al., 1994).
Interestingly, the four causative gly-
cine substitutions associated with
RDEB-I localize close to THD interrup-
tions (Figure 1b). Mutations G1907D
and G2088R disrupt the second and the
second to the last Gly–X–Y repeats of
subdomains COL10 and COL12, re-
spectively, whereas mutations G2472D
and G2775S disrupt the third and third
to the last Gly–X–Y repeats of COL18
and COL20, respectively (Figure 1b).
Besides mutation G1907D, no other
glycine substitution has been reported
in COL10, which adjoins the major
39-amino-acid non-collagenous hinge
domain of the THD. Interestingly,
the amino-acid sequence of COL10 is
highly conserved among species, and
RDEB dogs showing the hallmarks of
RDEB-I harbor a genetic mutation
(G1906A), which modifies the second
Gly–X–Y repeat of COL10 (Baldeschi
et al., 2003). In addition, mutations
G2472D and G2575S are the only
glycine substitutions so far identified
in COL18 and COL20, respectively.
Mutation G2088R, which disrupts the
penultimate Gly–X–Y of COL12, distin-
guishes itself from the other 33 mis-
sense mutations involving the 16
glycines in the middle of COL12 that
generate DEB as either dominant (23
cases) or recessive (10 cases) inheri-
tance (Dang and Murrell, 2008; Kern
et al., 2009). Recent studies showed
that the effects of mutations in col-
lagens are modulated by both the helix
propensity of the surrounding amino-
acid residues and the long-range mole-
cular interactions of the triple helix
(Xu et al., 2008). The Col7 THD is
organized into thermally stable and
labile domains. Our observations sug-
gest that the glycine substitutions loca-
lized at the edges of the collagenic
THD subdomains induce a pathological
phenotype characterized by a recessive
inheritance and a thermosensitive pattern
that is not observed in the case of Gly
mutations that affect the central portions
of the collagenic segments. Consistent
with the typical aggravation of RDEB in
several patients in summer, it has been
recently shown that the glycine substitu-
tions in Col7 may alter the thermal
stability of the molecule (Fritsch et al.,
2009). In this respect, in RDEB-I, the
predominant occurrence of cutaneous
lesions in the mucosa and flexural area
of the skin strengthens the hypothesis
that in RDEB-I the localization of the
amino-acid substitutions in specific
THD domains correlates with the synth-
esis of a thermo-labile Col7 that is
specifically less stable in the warmest
areas on the patient’s body. A localized
distribution of the involved areas of the
integument is observed in other skin
conditions, including oculo-cutaneous
albinism type 1, epidermolysis bullosa
simplex, and the bathing suit ichthyosis,
wherein it has been linked to tempera-
ture-sensitive amino-acid substitutions
in the gene alleles associated with the
condition (King et al., 1991; Morley
et al., 1995; Oji et al., 2006). Thus, the
thermosensitive nature of the genetic
mutations so far associated with RDEB-I
could be directly confirmed by expres-
sing mutant Col7 cDNAs in COL7A1-
null keratinocytes following the experi-
mental approaches recently reported by
Fritsch et al. (2009).
In conclusion, the clinical identifica-
tion of rare forms of inherited EB,
including RDEB-I, in young patients is
often difficult, and in several cases
hampers prediction on the evolution
of the condition. Our results suggest
that in DEB patients having amino-acid
substitutions affecting either the argi-
nine residues within the hydrophilic
highly conserved motifs of the Col7
THD domain or the glycines at the
borders of the collagenic subdomains,
the diagnosis of RDEB-I should be
considered, and, in turn, a simple
advice to alleviate the associated dis-
comforts in patients would be to keep
the temperature of the involved integu-
ment as low as possible, and consume
cold food and beverages.
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TO THE EDITOR
We wish to report the characteristic
differences that have been identified
between the ceramide (CER) profiles
of atopic dermatitis (AD) patients and
those of healthy individuals.
AD is characterized by impaired
stratum corneum (SC) functions, which
can be indicated by either an increase
in transepidermal water loss (TEWL) or
a decrease in water-holding function
(capacitance). On the other hand, a
close relationship between the im-
paired SC functions and CERs has been
reported (Elias, 1983; Melnik et al.,
1988; Yamamoto et al., 1991; Motta
et al., 1993, Paige et al., 1994; Di
Nardo et al., 1998; Matsumoto et al.,
1999; Macheleidt et al., 2002; Cho
et al., 2004). More recent research has
attempted—but failed—to uncover the
diagnostic potential of CER profiling
for skin pathologies, including AD
(Farwanah et al., 2005).
Human SC CERs can be divided into
11 groups according to their fatty acid
and sphingoid structures (Masukawa
et al., 2008), as shown in Figure 1a:
CER[NDS] contains non-OH fatty
acids [N] and dihydrosphingosines
[DS]; CER[NS] contains [N] and sphin-
gosines [S]; CER[NH] contains [N] and
6-hydroxy sphingosines [H]; CER[NP]
contains [N] and phytosphingosines
[P]; CER[ADS] contains a-OH fatty
acids [A] and [DS]; CER[AS] contains
[A] and [S]; CER[AH] contains [A] and
[H]; CER[AP] contains [A] and [P];
CER[EOS] contains ester-linked fatty
acids, and o-OH fatty acids [EO] and
[S]; CER[EOH] contains [EO] and [H];
and CER[EOP] contains [EO] and [P].
These classes have been further sub-
divided into species by chain length.
To date, we have identified 350 species
in human SC, using normal-phase
liquid chromatography coupled with
electrospray ionization–mass spectro-
metry (Masukawa et al., 2008, 2009;
it is worth noting that the former was
used to separate CERs into classes
based on the polarities). Using the same
procedure, we obtained an exhaustive
CER profile of the skin of AD patients
and healthy individuals to find a char-
acteristic difference between their pro-
files.
The study was conducted according
to the Declaration of Helsinki Princi-
ples. The protocol was approved by the
ethics committees of the Kao Corpora-
tion and Dokkyo Medical University.
Informed consent to participate in this
study was obtained from the patients.
Eight subjects with mild levels of AD
(four men and four women; age
range, 16–37; mean, 28) and seven
healthy individuals with no history of
skin disorder (four men and three
women; age range, 25–37; mean, 31)
were enrolled in this study. First, we
evaluated TEWL and capacitance, res-
pectively, using a Tewameter TM
210 and a Corneometer CM 825
(CourageþKhazaka Electronic GmbH,
Cologne, Germany) in the affected
and unaffected sites on the forearm
skin of AD patients and on the forearm
skin of healthy individuals. After con-
firming that TEWL and capacitance
were significantly higher and lower,
respectively, in the affected sites of the
AD patients as compared with those of
the unaffected sites of the AD patients
and healthy individuals (Figure 1b and
c), we sampled SC specimens from
these skin sites by performing tape
stripping 10 times. CERs were in turn
extracted from these specimens and
analyzed with an Agilent 1100
Series LC/MSD single-quadrupole sys-
tem equipped with an electrospray
ionization source, ChemStation soft-
ware, a 1,100-well-plate autosampler
(Agilent Technologies, Palo Alto, CA),
and an Inertsil SIL 100A-3, 1.5mm
i.d. 150mm column (GL Science,
Tokyo, Japan). These procedures are
detailed in our previous reports
(Masukawa et al., 2008, 2009).
The levels of total CER as well as
those of CER[NH], CER[NP], CER[EOS],
CER[EOH], and CER[EOP] classes were
found to be significantly lower in the
affected sites of AD patients as com-
pared with the normal skin sites of
healthy individuals (Figure 1d and e).
These findings are consistent with
previous findings (Imokawa et al.,
1991; Yamamoto et al., 1991; Di Nardo
et al., 1998; Bleck et al., 1999; Mache-
leidt et al., 2002). In addition, this study
revealed that the expression levels of
CER[AS] were significantly higher in the
affected sites of AD patients as com-
pared with the normal sites of healthy
individuals.
Abbreviations: AD, atopic dermatitis; CER, ceramide; SC, stratum corneum; TEWL, transepidermal water
loss
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